Navigation Links
Royal DSM and JLL create leading pharma services company in USD 2.6 bn transaction
Date:11/18/2013

vider of contract development and manufacturing services to the pharmaceutical, biopharmaceutical and agrochemical industries with a focus on drug products and APIs. In 2012 DPP realized net sales of €543 million with around 2,400 employees.

NewCo will have a unique breadth of service offerings with a focus on drug products and APIs with a wide range of technologies and will be able to offer comprehensive end-to-end solutions to a broad spectrum of companies ranging from large pharmaceutical and biotech companies to specialty pharma companies, generics and emerging pharma companies.

The combined company will also be a leader in proprietary softgel formulations for over-the-counter, prescription and nutritional consumer products. The exclusive synthesis products and intermediates are targeted to the crop protection, personal care, and fine chemicals products industries.

Jim Mullen, currently CEO of Patheon, will be appointed CEO of NewCo upon completion of the transaction. Mr. Mullen joined Patheon in 2011 as Chief Executive Officer. Prior to joining Patheon, he served as CEO and President at Biogen Idec Inc., one of the world's largest biotechnology companies from 2003 to 2010. He possesses over 30 years of industry experience, ranging from biotechnology and pharmaceuticals to specialty chemicals, as well as extensive expertise in pharmaceutical and biotech manufacturing, engineering, sales, marketing, mergers and acquisitions.

Feike Sijbesma, CEO and Chairman of the DSM Managing Board, said: "Fully in line with our strategy, this is for DSM Pharmaceutical Products the perfect way to accelerate growth and for DSM to maximize value for this business. By creating a global top CDMO organization I am convinced that NewCo as a standalone company will be able to create substanti
'/>"/>

SOURCE Royal DSM
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
2. Royalty Rates Take Center Stage in Biopharma Dealmaking
3. Home Affairs Committees Drugs Report: Angelus Foundation Says the Prime Minister Should Not Have Rejected a Royal Commission
4. NeuroSigma Invited to Present an Overview of eTNS for the Treatment of Epilepsy and Depression at The Royal Society of Medicine in London
5. Royalty Pharma Announces Proposal To Acquire Elan
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
8. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
9. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
10. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
11. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Calif. , Aug. 21, 2014 Asterias ... the emerging field of regenerative medicine, announced today the ... to the Company,s newly expanded Board of Directors. With ... eight directors, three of whom are independent. ... experience working with emerging growth companies. He is currently ...
(Date:8/20/2014)... Aug. 20, 2014 Northstar Global Business ... after months of hard work from many talented ... Snorenz formulation and package design.  The new formulation ... back into the product due to overwhelming evidence ... effects.  Snorenz Nighttime will also include these vitamins, ...
(Date:8/20/2014)... , Aug. 20, 2014  The National Association ... latest results achieved by the real-time, pseudoephedrine (PSE) ... National Precursor Log Exchange (NPLEx), automatically blocks unlawful ... down meth offenders and make arrests. Data released ... Kentucky blocked the sale of more ...
Breaking Medicine Technology:Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Abraxis BioScience,Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical,company, ... the role of SPARC (secreted protein acidic ... Abraxis' nanoparticle,albumin-bound (nab(TM)) tumor-targeting technology at the ... Meeting held,April 14-18, 2007 in Los Angeles., ...
... 19, 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation and TopoTarget ... on intravenous belinostat,(PXD101), a histone deacetylase (HDAC) ... are expected to be presented at two,upcoming ... one poster presentation discussing interim clinical,results with ...
Cached Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 2CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 3CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 4CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings 5
(Date:8/21/2014)... August 22, 2014 Top10BestSEOHosting.com has ... announces that iPage ( http://www.top10bestseohosting.com/go/iPage/ ) is one ... 2014. , The manager of Top10BestSEOHosting.com states, ... hosting supplier. Actually, these companies have outperformed their ... customer support. People can get the best web ...
(Date:8/21/2014)... August 21, 2014 Living in a ... atmosphere that comes along with it. A quality Home ... that such amenities are available. , ... Fayetteville, Georgia and Community Association Management, LLC made a ... Parks Company to provide an additional amenity for their ...
(Date:8/21/2014)... chronic kidney disease patients may be a strong indicator ... in the Journal of the American Society of ... Hopkins Bloomberg School of Public Health assert that coronary ... atherosclerosis in predicting the risk of heart disease among ... all patients with chronic kidney disease (CKD) die from ...
(Date:8/21/2014)... Dallas, TX (PRWEB) August 21, 2014 ... August 20 entertained residents with dementia at Silverado Turtle ... Improv Troupe, which consists of entertainers ranging from ages ... each time they perform their 40-minute set. The troupe's ... makes it universal and allows them to touch audiences ...
(Date:8/21/2014)... California (PRWEB) August 21, 2014 The ... initial plans for entertainment and programming for its inaugural ... On Sunday, October 12, 2014, from 11 a.m. to ... closed to all cars and the downtown will be ... activities, curated by Community Arts Resources (CARS), for all ...
Breaking Medicine News(10 mins):Health News:iPage Reviews Unveiled Online At Top10BestSEOHosting.com 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4
... software suite ensures that Builders Benefits is ready and ... , , BURLINGTON, Mass., June 23 HealthEdge, ... healthcare payors, today announced that Pennsylvania-based Builders Benefits has ... The advanced technology of HealthRules will now be used ...
... Scientists ... our brains function depending on whether we,re early risers or night owls. , ... (Vocus) June 23, 2009 -- Are you ... found that there are significant differences in the way our brains function depending on whether ...
... Solution Approach Catapults Company to Leadership Status in Providing Healthcare ... InfoLogix, Inc. (Nasdaq: IFLG ... the healthcare and commercial industries, announced today that the company ... the top ten consulting companies in healthcare IT ...
... Reasons for racial disparity remain unclear, researcher says, , TUESDAY, ... rare bone and soft tissue cancer Ewing,s sarcoma disproportionately strikes ... disease, males are more likely to die from it than ... Cancer . , Led by Dr. Sean Scully of ...
... June 23 The Certification Commission for Healthcare Information ... CCHIT Certified(R) 08 Ambulatory EHR, and meets 100% of ... "seal of approval" for EHR products provides a consensus-based, ... products with the CCHIT Certified(R) seal, physicians and other ...
... use Entrust grid cards, tokens and one-time-passcodes for strong ... 23 Healthcare networks and facilities rely on security ... have access to it. Importantly, this is no different ... make it possible. In fact, Entrust, Inc. (Nasdaq: ...
Cached Medicine News:Health News:Builders Benefits and HealthEdge(R) Complete Implementation of Award-Winning HealthRules(R) Product Suite 2Health News:Morning People and Night Owls Show Different Brain Function: University of Alberta Study 2Health News:InfoLogix Ranked as 7th Leading Consulting Company in Healthcare IT 2Health News:InfoLogix Ranked as 7th Leading Consulting Company in Healthcare IT 3Health News:Whites More Likely to Get Rare Bone Cancer 2Health News:The Criterions Medical Suite EHR 1.0.0 Receives 08 CCHIT Certification 2Health News:The Criterions Medical Suite EHR 1.0.0 Receives 08 CCHIT Certification 3Health News:Austrian IT Solutions Provider x-tention IT GmbH Implements Entrust Versatile Authentication Platform 2Health News:Austrian IT Solutions Provider x-tention IT GmbH Implements Entrust Versatile Authentication Platform 3
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades....
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare....
Smooth, blunt round spatula for manipulations of the corneal flap. Ideal for placement under the flap to expose the stromal interface....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 150o....
Medicine Products: